Le figaro fait la pub du vin

http://sante.lefigaro.fr/actualite/2015/08/21/24030-vin-est-bon-pour-coeura-faible-dose

Mais pas une seule citation!

Argument d'autorité d'un cardiologue 

http://www.ncbi.nlm.nih.gov/m/pubmed/26099843/?i=1&from=wine%20cardiovascular&filters=Review

http://www.sciencedirect.com/science/article/pii/S0024320515001526

http://www.atlantico.fr/decryptage/desole-non-aucune-etude-serieuse-jamais-prouve-que-boire-vin-maintenait-en-meilleure-sante-guy-andre-pelouze-1738503.html

In Vino Veritas (IVV) Study: Randomized trial comparing long-term effects of red and white wines on markers of atherosclerosis and oxidative stress

Authors: M. Taborsky1, P. Ostadal2, T. Adam3, D. Rihova2, 1Palacky University, Faculty of Medicine and Dentistry, 1st Dept of Internal Medicine-Cardiology - Olomouc - Czech Republic, 2Na Homolce Hospital - Prague - Czech Republic, 3Palacky University, Faculty of Medicine and Dentistry, Clinical Biochemistry - Olomouc - Czech Republic,

On behalf: Czech National Telemedicine Center

Topic(s): Epidemiology, lipids

Citation:  European Heart Journal ( 2014 ) 35 ( Abstract Supplement ), 181

Background: Since the early 90s, a growing body of evidence has indicated that the mild to moderate consumption of wine, has a protective effect against cardiovascular diseases. Methods: The IVV study is a first long-term, prospective, multicenter, randomized trial comparing the effects of red (RW) and white wine (WW) on atherosclerosis markers. 146 healthy subjects at mild to moderate risk of atherosclerosis have been randomized to a regular consumption of red wine (Pinot Noir) or white wine (Chardonnay-Pinot) /1 producer, 1 terroir/ for one year (women 0,2 l, men 0,3 l, 5 times a week, logbook for wine and other alcoholic beverages consumption). The primary endpoint is the level of HDL-cholesterol at one year, secondary endpoints are the levels of other markers of atherosclerosis (LDL-cholesterol, C-reactive protein) and oxidative stress (Lp-PLA2, Copeptin). Results: The level of HDL significantly decreased at 6 months in WW group in comparison with baseline value (Table 1). We did not detect any differences in the levels of ALT, GGT or bilirubin. Conclusion: In this prospective randomized trial we did not find between long-term mild consumption of red or white wine any clinically relevant differences in the lipid profile, CRP, fasting blood glucose, other markers of atherosclerosis i.e. Lp-PLA2 or copeptin, and liver function tests. Moreover, we were unable to confirm the hypothesis coming mostly from the retrospective studies that wine drinking is associated with elevation of HDL. The study is registred by ISRCTN under Ref. No. 54359610.

Table 1. Change in endpoints at 6 and 12 months from the enrollment according to wine

Mean (SD) Total White wine Red wine p N 146 74 72 HDL  At the enrollment 1.66 (0.58) 1.66 (0.66) 1.65 (0.50) 0.912  At 6 months 1.58 (0.48) 1.54 (0.52) 1.62 (0.43) 0.317  Difference 1 −0.09 (0.34) −0.14 (0.41) −0.04 (0.26) 0.074  p2 0.002 0.005 0.231  At 12 months 1.62 (0.49) 1.60 (0.53) 1.64 (0.46) 0.634  Difference 2 −0.04 (0.36) −0.07 (0.42) −0.01 (0.29) 0.362  p2 0.180 0.171 0.718

So HDL-C does not increase after wine consumption either white or red ones. If you look at the slides only 2 times a week exercise improve the so-called markers of atheroma...